Sign in

CIK 0001527352

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Nexalin Technology, Inc.

Sign in to watch
Ticker
NXL
Exchange
Nasdaq
Industry
Electromedical & Electrotherapeutic Apparatus
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
275566468
Phone
+1 832-260-0222
Business address
1776 YORKTOWN, SUITE 550, HOUSTON, TX, 77056
  1. 4 Open-market buy Chief Medical Officer bought 1,000 shares at $3.10 ($3,100)
  2. 4 Open-market buy Chief Medical Officer bought 1,000 shares at $2.98 ($2,980)
  3. 5 Insider Annual Insider Trading Report
  4. 5 Insider Annual Insider Trading Report
  5. 4 Open-market buy Chief Medical Officer bought 1,500 shares at $2.70 ($4,050)
  6. 4 Open-market buy Chief Medical Officer bought 3,000 shares at an average $2.57 ($7,700)
  7. 4 Open-market buy Chief Medical Officer bought 500 shares at $2.19 ($1,095)
  8. 4/A Grant or award 10% owner acquired 700,000 shares (grant or award)
  9. 4 Grant or award Director acquired 49,838 shares (grant or award)
  10. 4 Grant or award Director acquired 175,000 shares (grant or award)
  11. 4 Grant or award 10% owner acquired 700,000 shares (grant or award)
  12. 4/A Derivatives Options or other derivatives
  13. 4 Open-market buy Chief Medical Officer bought 1,000 shares at $0.95 ($950)
  14. 4 Open-market buy Chief Medical Officer bought 1,000 shares at $1.75 ($1,750)
  15. 4 Open-market buy Chief Medical Officer bought 1,619 shares at $0.71 ($1,149)
  16. 4 Open-market buy Chief Medical Officer bought 3,000 shares at an average $0.64 ($1,920)
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 2 of 3 · 58 filings